202 related articles for article (PubMed ID: 17328251)
1. Formulation of parenteral microemulsion containing itraconazole.
Rhee YS; Park CW; Nam TY; Shin YS; Chi SC; Park ES
Arch Pharm Res; 2007 Jan; 30(1):114-23. PubMed ID: 17328251
[TBL] [Abstract][Full Text] [Related]
2. Development of propofol-loaded microemulsion systems for parenteral delivery.
Ryoo HK; Park CW; Chi SC; Park ES
Arch Pharm Res; 2005 Dec; 28(12):1400-4. PubMed ID: 16392675
[TBL] [Abstract][Full Text] [Related]
3. Development of cyclosporine A microemulsion for parenteral delivery.
Yuan Y; Che X; Zhao M; Wang Y; Liu Y; Schwendeman A; Li S
J Microencapsul; 2015; 32(3):273-80. PubMed ID: 25761521
[TBL] [Abstract][Full Text] [Related]
4. The novel formulation design of O/W microemulsion for improving the gastrointestinal absorption of poorly water soluble compounds.
Araya H; Tomita M; Hayashi M
Int J Pharm; 2005 Nov; 305(1-2):61-74. PubMed ID: 16219433
[TBL] [Abstract][Full Text] [Related]
5. Development of intranasal nanovehicles of itraconazole and their immunological activities for the therapy of rhinovirus infection.
Lee JJ; Shim A; Jeong JY; Lee SY; Ko HJ; Cho HJ
Colloids Surf B Biointerfaces; 2016 Jul; 143():336-341. PubMed ID: 27022874
[TBL] [Abstract][Full Text] [Related]
6. Preparation methods for monodispersed garlic oil microspheres in water using the microemulsion technique and their potential as antimicrobials.
Zheng HM; Li HB; Wang da W; Liu D
J Food Sci; 2013 Aug; 78(8):N1301-6. PubMed ID: 23957416
[TBL] [Abstract][Full Text] [Related]
7. A mixed polymeric micellar formulation of itraconazole: Characteristics, toxicity and pharmacokinetics.
Yi Y; Yoon HJ; Kim BO; Shim M; Kim SO; Hwang SJ; Seo MH
J Control Release; 2007 Jan; 117(1):59-67. PubMed ID: 17097755
[TBL] [Abstract][Full Text] [Related]
8. Cremophor-free intravenous microemulsions for paclitaxel I: formulation, cytotoxicity and hemolysis.
Nornoo AO; Osborne DW; Chow DS
Int J Pharm; 2008 Feb; 349(1-2):108-16. PubMed ID: 17869459
[TBL] [Abstract][Full Text] [Related]
9. Investigation of surfactant/cosurfactant synergism impact on ibuprofen solubilization capacity and drug release characteristics of nonionic microemulsions.
Djekic L; Primorac M; Filipic S; Agbaba D
Int J Pharm; 2012 Aug; 433(1-2):25-33. PubMed ID: 22579578
[TBL] [Abstract][Full Text] [Related]
10. The influence of cosurfactants and oils on the formation of pharmaceutical microemulsions based on PEG-8 caprylic/capric glycerides.
Djekic L; Primorac M
Int J Pharm; 2008 Mar; 352(1-2):231-9. PubMed ID: 18068919
[TBL] [Abstract][Full Text] [Related]
11. D-optimal experimental approach for designing topical microemulsion of itraconazole: Characterization and evaluation of antifungal efficacy against a standardized Tinea pedis infection model in Wistar rats.
Kumar N; Shishu
Eur J Pharm Sci; 2015 Jan; 67():97-112. PubMed ID: 25445834
[TBL] [Abstract][Full Text] [Related]
12. Physicochemical characterization of rutaecarpine-loaded microemulsion system.
Choi HG; Park BJ; Kim JO; Park YJ; Kim JK; Yoo BK; Rhee JD; Jahng Y; Yong CS
Drug Dev Ind Pharm; 2005 Aug; 31(7):639-43. PubMed ID: 16207611
[TBL] [Abstract][Full Text] [Related]
13. Itraconazole-loaded microemulsions: formulation, characterization, and dermal delivery using shed snakeskin as the model membrane.
Promjan S; Boonme P
Pharm Dev Technol; 2023 Jan; 28(1):51-60. PubMed ID: 36547258
[TBL] [Abstract][Full Text] [Related]
14. Synergetic skin targeting effect of hydroxypropyl-β-cyclodextrin combined with microemulsion for ketoconazole.
Che J; Wu Z; Shao W; Guo P; Lin Y; Pan W; Zeng W; Zhang G; Wu C; Xu Y
Eur J Pharm Biopharm; 2015 Jun; 93():136-48. PubMed ID: 25845772
[TBL] [Abstract][Full Text] [Related]
15. The application of artificial neural networks in the prediction of microemulsion phase boundaries in PEG-8 caprylic/capric glycerides based systems.
Djekic L; Ibric S; Primorac M
Int J Pharm; 2008 Sep; 361(1-2):41-6. PubMed ID: 18571348
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of itraconazole after intravenous and oral dosing of itraconazole-cyclodextrin formulations.
Buchanan CM; Buchanan NL; Edgar KJ; Klein S; Little JL; Ramsey MG; Ruble KM; Wacher VJ; Wempe MF
J Pharm Sci; 2007 Nov; 96(11):3100-16. PubMed ID: 17712849
[TBL] [Abstract][Full Text] [Related]
17. Investigating effect of microemulsion components: In vitro permeation of ketoconazole.
Patel MR; Patel RB; Parikh JR; Solanki AB; Patel BG
Pharm Dev Technol; 2011 Jun; 16(3):250-8. PubMed ID: 20146553
[TBL] [Abstract][Full Text] [Related]
18. A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption.
Hong JY; Kim JK; Song YK; Park JS; Kim CK
J Control Release; 2006 Jan; 110(2):332-338. PubMed ID: 16297483
[TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of a microemulsion formulation for transdermal delivery of terbinafine.
Baboota S; Al-Azaki A; Kohli K; Ali J; Dixit N; Shakeel F
PDA J Pharm Sci Technol; 2007; 61(4):276-85. PubMed ID: 17933209
[TBL] [Abstract][Full Text] [Related]
20. Characterization and pharmacokinetic study of itraconazole solid dispersions prepared by solvent-controlled precipitation and spray-dry methods.
Sim T; Lim C; Lee JW; Kim DW; Kim Y; Kim M; Choi S; Choi HG; Lee ES; Kim KS; Kang W; Oh KT
J Pharm Pharmacol; 2017 Dec; 69(12):1707-1715. PubMed ID: 28872678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
